Literature DB >> 30472278

Achilles tendon thickening is associated with disease severity and plaque vulnerability in patients with coronary artery disease.

Takuya Hashimoto1, Yoshiyasu Minami2, Ryota Kakizaki1, Teruyoshi Nemoto1, Kazuhiro Fujiyoshi1, Kentaro Meguro3, Takao Shimohama3, Taiki Tojo3, Junya Ako4.   

Abstract

BACKGROUND: Tendon xanthomas are accumulations of collagen and macrophages, which contain cholesterol esters and a marker of high risk for coronary artery disease (CAD).
OBJECTIVE: The aim of the article was to clarify whether the presence of Achilles tendon thickening (ATT) was associated with disease severity and plaque vulnerability in patients with CAD.
METHODS: A total of 241 consecutive patients who underwent percutaneous coronary intervention and ATT assessment were analyzed. ATT was defined as Achilles tendon thickness of ≥9 mm on radiograph. The severity of CAD and plaque vulnerability was assessed by the findings on angiogram and optical coherence tomography, respectively.
RESULTS: ATT was found in 44 patients (18.2%). The frequency of multivessel disease (79.6% vs 58.4%, P = .009) and left main lesion (13.6% vs 3.1%, P = .004) was significantly higher in patients with ATT (ATT group) than in patients without ATT (no ATT group). Multivariate logistic regression analyses demonstrated that the presence of ATT was independently associated with the presence of multivessel disease (odds ratio, 2.33; 95% confidence interval, 1.08-5.46; P = .031). The ATT group had a higher prevalence of intimal vascular channels (50.0% vs 24.7%, P = .018) and macrophage accumulation (58.3% vs 33.3%, P = .028) in culprit plaque than the no ATT group.
CONCLUSIONS: Patients with the presence of ATT had a higher prevalence of multivessel coronary disease and left main coronary artery disease than with patients without ATT. The presence of ATT was also associated with vulnerable features, including intimal vascular channels and macrophage accumulation in culprit plaques.
Copyright © 2018 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dyslipidemia; Familial hypercholesterolemia; Multivessel disease; Optical coherence tomography; Vulnerable plaque

Mesh:

Substances:

Year:  2018        PMID: 30472278     DOI: 10.1016/j.jacl.2018.10.007

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  4 in total

1.  Familial hypercholesterolemia and vulnerability of coronary plaque in patients with coronary artery disease.

Authors:  Masahiro Katamine; Yoshiyasu Minami; Takuya Hashimoto; Junya Ako
Journal:  Pract Lab Med       Date:  2021-01-19

2.  Coronary lesion complexity in patients with heterozygous familial hypercholesterolemia hospitalized for acute myocardial infarction: data from the RICO survey.

Authors:  Hermann Yao; Michel Farnier; Laura Tribouillard; Frédéric Chague; Philippe Brunel; Maud Maza; Damien Brunet; Luc Rochette; Florence Bichat; Yves Cottin; Marianne Zeller
Journal:  Lipids Health Dis       Date:  2021-05-04       Impact factor: 3.876

3.  Effects of lipid metabolism on mouse incisor dentinogenesis.

Authors:  Yutaro Kurotaki; Nobuhiro Sakai; Takuro Miyazaki; Masahiro Hosonuma; Yurie Sato; Akiko Karakawa; Masahiro Chatani; Mie Myers; Tetsuo Suzawa; Takako Negishi-Koga; Ryutaro Kamijo; Akira Miyazaki; Yasubumi Maruoka; Masamichi Takami
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

4.  Possible Neoangiogenesis in Achilles Tendon Xanthoma with Familial Hypercholesterolemia: A Novel Approach to Achilles Tendon Xanthoma.

Authors:  Tetsu Tanaka; Kazuyuki Yahagi; Osamu Wada; Kai Ninomiya; Yu Horiuchi; Masahiko Asami; Hitomi Yuzawa; Kota Komiyama; Jun Tanaka; Jiro Aoki; Akitake Suzuki; Kazuho Ishizaki; Kengo Tanabe
Journal:  Intern Med       Date:  2021-06-12       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.